Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Vulvar Neoplasms × cemiplimab × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 19 Lung Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 5 Skin Neoplasms 5 Neoplasms 5 Urinary Bladder Neoplasms 4 Neoplasm Metastasis 4 Head and Neck Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma, Merkel Cell 4 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Mycosis Fungoides 3 Melanoma 3 Carcinoma, Squamous Cell 3 Breast Neoplasms 3 Adenocarcinoma 3 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Oropharyngeal Neoplasms 2 Mesothelioma, Malignant 2 Lymphoma, T-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Colonic Neoplasms 2 Carcinoma, Hepatocellular 2 Carcinoma 2 Vulvar Neoplasms 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1

Interventions

Methods 6 Surveys and Questionnaires 4 Radiotherapy 4 Cisplatin 4 pembrolizumab 3 Sentinel Lymph Node Biopsy 3 Radiosurgery 3 Palliative Care 3 Indocyanine Green 3 Early Intervention, Educational 3 Brachytherapy 3 Bleomycin 3 tremelimumab 2 durvalumab 2 Surgical Procedures, Operative 2 Radiation 2 Imiquimod 2 Gemcitabine 2 Electrochemotherapy 2 Drug Therapy 2 Dehydroepiandrosterone 2 Carboplatin 2 Biopsy 2 Bevacizumab 2 Behavior Therapy 2 zimberelimab 1 tivozanib 1 sapropterin 1 nanocis 1 liposomal doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07101848 2025-08-03

BRAVA VULVAR

Hospital Israelita Albert Einstein

Phase 2 Not yet recruiting

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡